Wayne Mullett
About Wayne Mullett
Wayne Mullett is the Global Director of Supply Chain and Development at Boston Scientific, with extensive experience in pharmaceutical research and development.
Company
Wayne Mullett is currently employed at Boston Scientific. He has held the position of Global Director, Supply Chain and Development since 2019. Boston Scientific is a globally recognized medical device manufacturer known for its innovative solutions in the healthcare sector. Mullett is based in Ottawa, Ontario, Canada.
Title
Wayne Mullett holds the title of Global Director, Supply Chain and Development at Boston Scientific. In this role, Mullett oversees the complex logistics network and development initiatives, ensuring efficient operations and alignment with the company's strategic goals. His responsibilities include managing supply chain processes and driving development from early-phase research to product commercialization.
Education and Expertise
Wayne Mullett has a robust academic background in Chemistry and Biochemistry. He holds a Ph.D. in Chemistry from Carleton University (1995-2000) and a Bachelor of Science in Biochemistry from Memorial University of Newfoundland (1991-1995). Mullett has extensive expertise in pharmaceutical sample preparation, analytical techniques, and advanced methods such as UPLC, HPLC-UV, LC-MS/MS, GC-MS, IC, ICP-OES/MS, dissolution, and titration.
Previous Positions
Mullett's career includes significant roles in multiple organizations before joining Boston Scientific. From 2013 to 2019, he served as Director of Research and Development at BTG. Before that, he was Director of Radiopharmaceutical Development at Nordion from 2009 to 2013. Earlier, Mullett worked at Merck, starting as a Senior Research Chemist (2002-2005) and later as a Research Fellow (2005-2009). Each role contributed to his comprehensive skills in project management, research leadership, and pharmaceutical development.
Industry Experience
Wayne Mullett has over a decade of experience leading multidisciplinary groups in the pharmaceutical and healthcare sectors. His expertise includes overseeing early-phase research projects through to product commercialization. He also has 8 years of experience as a Project Group Leader for API synthesis/form selection and clinical formulation development in GLP/GMP environments. His extensive publication record highlights his proficiency in pharmaceutical sample preparation and analytical methodologies.